US Patent Issued to The Translational Genomics Research Institute, The Regents of the University of California for and on behalf of the San Francisco campus on Jan. 13 for "Early detection of drug-resistant mycobacterium tuberculosis" (Arizona, California Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,877, issued on Jan. 13, was assigned to The Translational Genomics Research Institute (Phoenix) and The Regents of the University of California for and on behalf of the San Francisco campus (San Francisco).

"Early detection of drug-resistant mycobacterium tuberculosis" was invented by David Engelthaler (Phoenix), Christopher Allender (Phoenix), James Schupp (Phoenix) and John Metcalfe (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to oligonucleotides, methods, and kits for detecting an antibiotic-resistant subpopulation within a heteroresistant population of Mycobacterium tuberculosis in a sample. An ampl...